News

2017 Jun 21

Enzyme Regulates the Ability of Radiation Therapy to Activate Anti-Tumor Immunity

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy’s ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study. Their... Read more

2017 Jun 21

Could a blood test predict how cancer spreads in children?

David Lyden, M.D., Ph.D., discusses his work trying to isolate tumor exosomes as predictors of metastasis. Read more

2017 Jun 21

Injections of cash for young blood cancer researchers

Four young scientists have received fellowships to pursue lymphoma and leukemia research. Read more

Dr. Eloise Chapman-Davis and Dr. Juan R. Cubillos-Ruiz

2017 Jun 20

Ovarian Cancer: Overcoming Obstacles to Immunotherapy

Juan R. Cubillos-Ruiz, Ph.D., and Eloise Chapman-Davis, M.D., discuss the latest treatments for ovarian cancer. Read more

2017 Jun 20

Global trends in gastroesophageal cancers

Manish Shah, M.D., joins a group of international experts in gastroesophageal cancers for a discussion about global trends in gastric cancers. Read more

2017 Jun 20

Chomping at the bit: Harnessing autophagy to kill cancer

Lorenzo Galluzzi, Ph.D, is investigating the unrealized potential of autophagy modulation for cancer therapy. Read more

Tessa Cigler, M.D. uses cold caps to preserve hair during chemotherapy

2017 Jun 19

Evidence builds for scalp cooling

Two-thirds of patients who underwent scalp cooling treatment during breast cancer chemotherapy retained their hair, according to a study by Tessa Cigler, M.D. Read more

2017 Jun 19

Researchers develop first-ever human tissue platform to test drugs for colon cancer

The first-ever “disease in a Petri dish” platform that models human colon cancer derived from stem cells has been developed by a team led by Todd Evans and Shuibing Chen. Read more

2017 Jun 15

Novel Regimens Explored for Rare DLBCL Subtypes

Sarah Rutherford, M.D., discusses therapy for double-hit and double-protein expressor lymphomas. Read more

Innovation from Weill Cornell Medicine scientists + the best medical care from NewYork-Presbyterian doctors puts Meyer Cancer Center first in NYC cancer care.

2017 Jun 14

How mixed reality is transforming collaborative cancer research

Computational biologist Alex Sigaras explains how Weill Cornell Medicine is using virtual and "mixed" reality to enhance cancer research. Read more

2017 Jun 09

‘How long have I got?’: Why many cancer patients don’t have answers

Holly Prigerson and Ronald Adelman discuss the importance of honest and frank communication between oncologists and their patients. Read more

Weill Cornell and NewYork-Presbyterian experts at ASCO17

2017 Jun 09

Meyer experts weigh in on ASCO17 findings

Physician-scientists from the Meyer Cancer Center were the go-to experts when it came to commenting on several studies presented at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting in Chicago. Read more

2017 Jun 07

Imaging technique shows molecular machinery at work

The Blanchard Lab has developed new imaging methods that allow researchers to track the individual protein molecules on the surface of cells. Read more

2017 Jun 05

Study questions value of costly cancer-drug combinations

Eleni Andreopoulou, M.D, comments on a study about a breast cancer drug combination that has stirred debate about costs. Read more

2017 Jun 02

Mobile app helps reduce readmissions for colorectal patients

Clinical research fellow Matthew Symer, M.D., discusses his new study on mobile apps and colorectal surgery patients. Read more

2017 Jun 02

Cantley named a "Giant of Cancer Care"

Lewis C. Cantley, Ph.D., was inducted into the OncLive 2017 Giants of Cancer Care recognition program. Read more

2017 Jun 02

Patient-specific method improves monitoring of leukemia cells

A technique developed by Weill Cornell Medicine investigators can detect cancer cells surviving therapy in the most common form of leukemia in adults more sensitively and precisely than traditional microscopic observation. Read more

2017 Jun 01

Inside NYP: Dr. Richard Silver

Richard Silver, M.D., shares his involvement with the groundbreaking imatinib cancer pill and what he’s gleaned from 60 years working in medicine. Read more

2017 May 31

First clinical trial of new targeted molecular therapy in U.S. takes aim at incurable prostate cancer

Weill Cornell clinicians have begun the first clinical trial in the United States that uses a radiopharmaceutical to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy. Read more

2017 May 30

Singh wins grant from defense department for cancer research

A large grant will allow Ithaca affiliate Ankur Singh to further his study of diffuse large B-cell lymphoma and develop a lymphoma subtype-specific organoid to evaluate the pre-clinical and clinical outcomes of a new class of pathway targeting novel anti-tumor therapeutics. Read more

News

Enzyme Regulates the Ability of Radiation Therapy to Activate Anti-Tumor Immunity

Could a blood test predict how cancer spreads in children?

Injections of cash for young blood cancer researchers

Ovarian Cancer: Overcoming Obstacles to Immunotherapy

Global trends in gastroesophageal cancers

Chomping at the bit: Harnessing autophagy to kill cancer

Evidence builds for scalp cooling

Researchers develop first-ever human tissue platform to test drugs for colon cancer

Novel Regimens Explored for Rare DLBCL Subtypes

How mixed reality is transforming collaborative cancer research

‘How long have I got?’: Why many cancer patients don’t have answers

Meyer experts weigh in on ASCO17 findings

Imaging technique shows molecular machinery at work

Study questions value of costly cancer-drug combinations

Mobile app helps reduce readmissions for colorectal patients

Cantley named a "Giant of Cancer Care"

Patient-specific method improves monitoring of leukemia cells

Inside NYP: Dr. Richard Silver

First clinical trial of new targeted molecular therapy in U.S. takes aim at incurable prostate cancer

Singh wins grant from defense department for cancer research

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters